Phase IIa Study Evaluating AZD7798 in Crohn's Disease

Clinical trial NCT06450197 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06450197
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Crohn's Disease

Start date: 2024-08-28
Primary completion: 2026-04-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.